Overview
Welcome to Dwaey, specifically on TRANEXA 1000 mg/10 ml Solution for Injection page.
This medicine contains an important and useful components, as it consists of Tranexamic acid.
TRANEXA 1000 mg/10 ml is available in the market in concentration 1000 mg/10 ml and in the form of Solution for Injection.
MICROSYNERGY PHARMACEUTICALS FZCO is the producer of TRANEXA 1000 mg/10 ml and it is imported from UAE, The most popular alternatives of TRANEXA 1000 mg/10 ml are listed downward .
Tranexamic acid is an antifibrinolytic agent that competitively inhibits breakdown of fibrin clots. It blocks binding of plasminogen and plasmin to fibrin, thereby preventing haemostatic plug dissolution.
Mild to moderate renal impairment, irregular menstrual bleeding, previous history of thromboembolic disease, haematuria. Monitor closely in disseminated intravascular coagulation. Monitor LFT and eye examination regularly during long-term use. Discontinue if disturbance in colour vision occurs. Avoid IV inj rate >1 ml/minute due to risk of hypotension. Pregnancy, lactation.
Severe renal failure, active intravascular clotting, thromboembolic disease, colour vision disorders, subarachnoid bleeding.
Pregnancy category: B
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.
Tranexamic acid
Tranexamic acid
Tranexamic acid
Tranexamic acid
Tranexamic acid
Tranexamic acid
Tranexamic acid
Tranexamic acid